2022-06-07 | NDAQ:MRNA | Press Release | Moderna Inc. - Stockhouse
6/7/2022 12:00:00 AM2 years 10 months ago
by Stockhouse.com
by Stockhouse.com
(2022-06-07 | NDAQ:MRNA) Moderna Announces First Participants Dosed in Phase 3 Study of Seasonal Influenza Vaccine Candidate (mRNA-1010)
mRNA-1010 is Moderna's first seasonal influenza vaccine candidate to enter a Phase 3 trialmRNA-1010 is one of several influenza vaccine candidates being developed in Moderna's respiratory portfolioMo… [+7598 chars]
full article...